|
Volumn 48, Issue 9, 2013, Pages 744-752
|
Impact of a clinical decision support system on pharmacy clinical interventions, documentation efforts, and costs
|
Author keywords
antibiotic stewardship; clinical decision support system; costs; documentation; interventions; pharmacy; surveillance
|
Indexed keywords
AZITHROMYCIN;
AZITHROMYCIN PLUS CEFTRIAXONE;
CEFTRIAXONE;
CIPROFLOXACIN;
CIPROFLOXACIN PLUS LEVOFLOXACIN;
CLINDAMYCIN;
COTRIMOXAZOLE;
DAPTOMYCIN;
DORIPENEM;
DOXYCYCLINE;
ERYTHROPOIETIN;
ETIRACETAM;
FAMOTIDINE;
FIBRINOGEN RECEPTOR ANTAGONIST;
FLUCONAZOLE;
LEVOFLOXACIN;
LEVOTHYROXINE;
LINEZOLID;
METOCLOPRAMIDE;
METRONIDAZOLE;
PANTOPRAZOLE;
PHENYTOIN;
PIPERACILLIN PLUS TAZOBACTAM;
SNAKE VENOM ANTISERUM;
TIGECYCLINE;
UNCLASSIFIED DRUG;
VANCOMYCIN;
ARTICLE;
CLINICAL DECISION MAKING;
CLINICAL DECISION SUPPORT SYSTEM;
DRUG SURVEILLANCE PROGRAM;
HEALTH CARE COST;
HEALTH CARE PERSONNEL;
HUMAN;
MEDICAL DOCUMENTATION;
PHARMACY;
|
EID: 84886666696
PISSN: 00185787
EISSN: 19451253
Source Type: Journal
DOI: 10.1310/hpj4809-744 Document Type: Article |
Times cited : (48)
|
References (12)
|